Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients
Clinical trial NCT03393845 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03393845
- Sponsor
- Nancy Chan, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-29
- Primary completion
- 2023-08-04
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.